Needham Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)

November 13, 2025 4:46 AM UTC Send to a Friend
Needham analyst Mike Matson reiterated a Buy rating and $3.00 price target on Lucid Diagnostics Inc (NASDAQ: LUCD).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login